Hoth Historical Cash Flow
| HOTH Stock | USD 0.83 0.01 1.22% |
Analysis of Hoth Therapeutics cash flow over time is an excellent tool to project Hoth Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 2.2 K or Depreciation of 106 as it is a great indicator of Hoth Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Hoth Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hoth Therapeutics is a good buy for the upcoming year.
Hoth |
About Hoth Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Hoth balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Hoth's non-liquid assets can be easily converted into cash.
Hoth Therapeutics Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Hoth Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Hoth Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Hoth Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Hoth Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.As of now, Hoth Therapeutics' Sale Purchase Of Stock is decreasing as compared to previous years. The Hoth Therapeutics' current Change To Liabilities is estimated to increase to about 646.4 K, while Investments are projected to decrease to (7.9 K).
Hoth Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Hoth Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hoth Therapeutics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 1.6M | 738.8K | 5.9M | (2.1M) | 2.9M | 1.6M | |
| Other Cashflows From Financing Activities | 163.0 | 56.3K | 359.5K | 51.0K | 2.4K | 2.2K | |
| Depreciation | 1.2K | 1.2K | 1.0K | 124.0 | 111.6 | 106.02 | |
| Total Cash From Operating Activities | (4.9M) | (6.1M) | (12.1M) | (9.3M) | (8.4M) | (8.9M) | |
| Change To Operating Activities | (13.9K) | (97.7K) | 20.2K | (5.4K) | (6.2K) | (6.5K) | |
| Net Income | (7.7M) | (7.2M) | (14.3M) | (11.4M) | (7.8M) | (8.2M) | |
| Total Cash From Financing Activities | 7.5M | 8.7M | 18.2M | 6.0M | 11.3M | 8.8M | |
| End Period Cash Flow | 1.9M | 2.6M | 8.5M | 6.4M | 9.3M | 4.8M | |
| Change To Netincome | 143.1K | 2.5M | 1.2M | 1.7M | 1.5M | 1.2M | |
| Change To Liabilities | 92.8K | 267.4K | (152.0K) | 535.3K | 615.6K | 646.4K | |
| Stock Based Compensation | 2.5M | 737.7K | 1.3M | 620.8K | 216.4K | 205.6K | |
| Free Cash Flow | (5.0M) | (6.3M) | (12.2M) | (9.4M) | (8.4M) | (8.9M) | |
| Change In Working Capital | 169.6K | (131.8K) | 529.9K | 594.5K | (748.1K) | (710.6K) | |
| Begin Period Cash Flow | 282.6K | 1.9M | 2.6M | 8.5M | 6.4M | 3.9M | |
| Other Non Cash Items | 95K | 507.0K | 370.8K | 858.8K | (70.1K) | (66.6K) | |
| Issuance Of Capital Stock | 7.5M | 8.7M | 17.8M | 6.0M | 11.3M | 9.4M |
Currently Active Assets on Macroaxis
When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.27) | Return On Assets (0.46) | Return On Equity (0.83) |
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.